Integrating Collaborative TB and HIV Services within a Comprehensive Package of Care for People who Inject Drugs: Consolidated Guidelines

These new guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care. The guidelines provide an update to the 2008 Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach, and consolidate the latest recommendations relating to the management of TB, HIV-associated TB, HIV, viral hepatitis B and hepatitis C, and drug dependence. Although the main focus of this guidance is to benefit PWID, many of the recommendations are also relevant for those who use drugs and do not currently inject, but are in need of the respective services.